Changes in elemental concentrations in LNCaP cells are associated with a protective effect of neuropeptides on etoposide-induced apoptosis

被引:21
作者
Salido, M
Vilches, J
Roomans, GM
机构
[1] Univ Cadiz, Sch Med, Dept Cell Biol, Cadiz 11003, Spain
[2] Uppsala Univ, Dept Med Cell Biol, S-75123 Uppsala, Sweden
关键词
apoptosis; prostate carcinoma; electron probe X-ray microanalysis; intracellular ions; neuropeptides; bombesin; calcitonin;
D O I
10.1016/j.cellbi.2004.03.008
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
One of the mechanisms that has been put forward for the development of the androgen-resistant status is neuroendocrine differentiation. Neuroendocrine cells secrete neuropeptides that may represent one of the possible molecular bases by which hormone-dependent prostate cancer cells could escape treatment. LNCaP prostate cancer cells were treated with either etoposide or neuropeptides. Morphological changes related to apoptosis and cell viability were assessed. Changes in intracellular ion content were quantitatively analyzed by electron probe X-ray microanalysis. Etoposide treatment consistently induces a decrease in K and an increase in Na, which are inhibited by bombesin or calcitonin. The Na/K ratio increased markedly after exposure to etoposide, and both bombesin and calcitonin blocked this increase. Etoposide also caused changes in the intracellular P and S concentrations that to a large extent Could be blocked by neuropeptides. These results support the hypothesis that neuropeptides confer antiapoptotic capabilities onto non-neuroendocrine cells in close proximity to neuroendocrine cells. (C) 2004 International Federation for Cell Biology. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:397 / 402
页数:6
相关论文
共 20 条
[1]  
Aprikian AG, 1998, PROSTATE, P52
[2]   Calcitonin is a prostate epithelium-derived growth stimulatory peptide [J].
Chien, J ;
Ren, Y ;
Wang, YQ ;
Bordelon, W ;
Thompson, E ;
Davis, R ;
Rayford, W ;
Shah, G .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2001, 181 (1-2) :69-79
[3]   Molecular characterization of prostatic small-cell neuroendocrine carcinoma [J].
Clegg, N ;
Ferguson, C ;
True, LD ;
Arnold, H ;
Moorman, A ;
Quinn, JE ;
Vessella, RL ;
Nelson, PS .
PROSTATE, 2003, 55 (01) :55-64
[4]  
Cox ME, 1999, CANCER RES, V59, P3821
[5]  
Dallaporta B, 1998, J IMMUNOL, V160, P5605
[6]   Changes in elemental content during apoptotic cell death studied by electron probe X-ray microanalysis [J].
Fernández-Segura, E ;
Cañizares, FJ ;
Cubero, MA ;
Warley, A ;
Campos, A .
EXPERIMENTAL CELL RESEARCH, 1999, 253 (02) :454-462
[7]   Apoptosis resistance of neuroendocrine phenotypes in prostatic adenocarcinoma [J].
Fixemer, T ;
Remberger, K ;
Bonkhoff, H .
PROSTATE, 2002, 53 (02) :118-123
[8]   Identification of differentially expressed genes during cyclic adenosine monophosphate-induced neuroendocrine differentiation in the human prostatic adenocarcinoma cell line LNCaP [J].
Goodin, JL ;
Rutherford, CL .
MOLECULAR CARCINOGENESIS, 2002, 33 (02) :88-98
[9]   Neuroendocrine pathogenesis in adenocarcinoma of the prostate [J].
Hansson, J ;
Abrahamsson, PA .
ANNALS OF ONCOLOGY, 2001, 12 :S145-S152
[10]  
Hoosein N.M., 1998, FRONT BIOSCI-LANDMRK, V3, P1274